| 2026-08-10 | Press release | BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM |
| 2026-08-06 | Earnings deck | Presentation |
| 2026-08-06 | Press release | BioMarin Reports Second Quarter 2026 Financial and Operating Results |
| 2026-08-05 | Press release | BioMarin Pharmaceutical Second Quarter 2026 Conference Call |
| 2026-07-30 | Press release | BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30p |
| 2026-07-27 | Press release | BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Ne |
| 2026-07-13 | Press release | U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vo |
| 2026-06-16 | Press release | BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026 |
| 2026-05-20 | Press release | BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia |
| 2026-05-18 | Press release | BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency |
| 2026-05-04 | Press release | BioMarin Reports First Quarter 2026 Financial and Operating Results |
| 2026-05-04 | Earnings deck | Presentation
of Q1 2026, PDF file, (opens in new window) |
| 2026-05-04 | Press release | Press Release
of Q1 2026, PDF file, (opens in new window) |
| 2026-05-02 | Press release | BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and |
| 2026-04-27 | Press release | BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET |
| 2026-04-27 | Press release | BioMarin Completes Acquisition of Amicus Therapeutics |
| 2026-04-21 | Press release | BioMarin Announces Board Leadership Transition |
| 2026-03-12 | Press release | BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and A |
| 2026-02-27 | Press release | U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Ol |
| 2026-02-24 | Press release | BioMarin to Participate in Four Upcoming Investor Conferences in March |
| 2026-02-23 | Earnings deck | Presentation Open Event Link, PDF file, February 23, 2026, (opens in new window) |
| 2026-02-23 | Press release | https://www.prnewswire.com/news-releases/biomarin-reports-fourth-quarter-and-full-year-2025-financial-and-operating-resu |
| 2026-02-23 | Press release | Press Release Open Event Link, PDF file, February 23, 2026, (opens in new window) |
| 2026-02-23 | Press release | BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results |
| 2026-02-17 | Press release | BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, |
| 2026-02-12 | Press release | BioMarin Announces Closing of Private Offering of Senior Notes |
| 2026-01-29 | Press release | BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term |
| 2026-01-26 | Press release | BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility |
| 2026-01-12 | Press release | BioMarin Appoints Arpit Davé Chief Digital and Information Officer |
| 2026-01-12 | Presentation | Presentation Open Event Link, PDF file, January 12, 2026, (opens in new window) |
| 2026-01-08 | Press release | BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm |
| 2025-10-27 | Earnings deck | Presentation of Q3 2025 Report, (opens in new window) |
| 2025-08-01 | Earnings deck | Presentation of Q2 2025 Report, (opens in new window) |
| 2025-04-30 | Earnings deck | Presentation of First Quarter 2025, PDF file, (opens in new window) |
| 2025-02-19 | Earnings deck | Presentation of Fourth Quarter 2024, PDF file, (opens in new window) |
| 2025-02-19 | Press release | Press Release of Fourth Quarter 2024, PDF file, (opens in new window) |
| 2025-01-13 | Presentation | 43rd Annual J.P. Morgan Healthcare Conference |
| 2024-10-29 | Press release | Press Release of Third Quarter 2024, PDF file, (opens in new window) |
| 2024-08-05 | Press release | Press Release of Second Quarter 2024, PDF file, (opens in new window) |
| 2024-04-24 | Press release | Press Release of First Quarter 2024, PDF file, (opens in new window) |